0001179110-16-020725.txt : 20160302 0001179110-16-020725.hdr.sgml : 20160302 20160302183233 ACCESSION NUMBER: 0001179110-16-020725 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160229 FILED AS OF DATE: 20160302 DATE AS OF CHANGE: 20160302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICINES CO /DE CENTRAL INDEX KEY: 0001113481 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043324394 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-290-6000 MAIL ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: MEDICINES CO/ MA DATE OF NAME CHANGE: 20000504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MEANWELL CLIVE CENTRAL INDEX KEY: 0001204787 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31191 FILM NUMBER: 161478935 MAIL ADDRESS: STREET 1: THE MEDICINES CO STREET 2: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 edgar.xml FORM 4 - X0306 4 2016-02-29 0 0001113481 MEDICINES CO /DE MDCO 0001204787 MEANWELL CLIVE 8 SYLVAN WAY PARSIPPANY NJ 07054 1 1 0 0 CEO Common Stock 2016-02-29 4 A 0 305 27.34 A 314990 D Common Stock 2016-03-01 4 A 0 45400 0 A 360390 D Common Stock 2016-03-02 4 F 0 21600 33.85 D 338790 D Stock Option (right-to-buy) 33.04 2016-03-01 4 A 0 297776 0 A 2026-03-01 Common Stock 297776 297776 D Shares of common stock acquired pursuant to The Medicines Company Employee Stock Purchase Plan ('ESPP') for the ESPP purchase period beginning September 1, 2015 and ending February 29, 2016. In accordance with the terms of the ESPP, these shares were purchased based on 85% of the fair market value closing price of the issuer's common stock on February 29, 2016. Shares of restricted stock vest in 25% increments on each anniversary of the date of grant, until fully vested. Shares of common stock were withheld for payment of taxes in connection with the vesting of 41,135 shares of restricted stock from previously reported grants. The option vests in forty-eight equal installments beginning April 1, 2016. /s/ Stephen M. Rodin, Attorney-in-Fact for Clive A. Meanwell 2016-03-02